In a recent transaction, William C. Bertrand Jr., the Chief Operating Officer of Adaptimmune Therapeutics PLC (NASDAQ:ADAP), ...

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, announced today that its Board of Directors has ...

DouYu shares are trading higher by 28.5% during Thursday's session. The company appointed Simin Ren Co-CEO and announced a ...

I-Mab (NASDAQ: IMAB) (the "Company"), a U.S.-based, global biotech company, focused on the development of precision ...

BioLineRx (BLRX) announced that its Board of Directors has approved a change in the number of its ordinary shares represented by American ...

Evaxion Biotech A/S announced that it has implemented a change in the ratio of its American Depositary Shares (ADSs) from one ADS representing ten ordinary shares to one ADS representing fifty ...

Infosys, India’s second-largest software services provider, reported 4.6% rise in its net profit at ₹6,806 crore for the ...

This prospectus relates to the potential resale from time to time by AstraZeneca Holdings B.V. or its permitted transferees or assignees of up ...

DouYu International Holdings shares surged Thursday after the company named a new co-chief executive following the late-2023 arrest of its founder and chief executive, as well as declared a $9.94 ...

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company pursuing life-changing therapies ...

Evaxion Biotech A/S announced a change in the ratio of its American Depositary Shares (ADSs) to ordinary shares, moving from one ADS representing ten ordinary shares to one ADS representing fifty ...